日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trial

利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松龙联合大剂量甲氨蝶呤和鞘内化疗治疗新诊断的血管内大B细胞淋巴瘤(PRIMEUR-IVL):一项多中心、单臂II期试验的长期结果

Shimada, Kazuyuki; Yamaguchi, Motoko; Kuwatsuka, Yachiyo; Matsue, Kosei; Sato, Keijiro; Kusumoto, Shigeru; Nagai, Hirokazu; Takizawa, Jun; Fukuhara, Noriko; Nagafuji, Koji; Miyazaki, Kana; Ohtsuka, Eiichi; Okamoto, Akinao; Sugita, Yasumasa; Uchida, Toshiki; Kayukawa, Satoshi; Wake, Atsushi; Ennishi, Daisuke; Kondo, Yukio; Meguro, Akiko; Kin, Yoshihiro; Minami, Yosuke; Hashimoto, Daigo; Nishiyama, Takahiro; Shimada, Satoko; Masaki, Yasufumi; Okamoto, Masataka; Atsuta, Yoshiko; Kiyoi, Hitoshi; Suzuki, Ritsuro; Nakamura, Shigeo; Kinoshita, Tomohiro

Protein C deficiency with recurrent systemic thrombosis associated with compound heterozygous PROC missense variants.

伴有复合杂合 PROC 错义变异的复发性全身性血栓形成的蛋白 C 缺乏症

Shiba Mikio, Higo Shuichiro, Morishita Yu, Ichibori Yasuhiro, Kin Yoshihiro, Sakata Yasushi, Higuchi Yoshiharu

Successful Dasatinib Treatment of Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinoma and BCR-ABL1-Positive Chronic Myeloid Leukemia: A Case Report

达沙替尼成功治疗表皮生长因子受体突变型肺腺癌和 BCR-ABL1 阳性慢性粒细胞白血病:病例报告

Tsukaguchi, Akihiro; Minami, Seigo; Yasuoka, Hironao; Kin, Yoshihiro